| Front Page |
|
Bennett Wins Novartis Award NIDDK's Dr. Peter Bennett received a Novartis Award in Diabetes during the American Diabetes Association's meeting in June. The Long-Standing Achievement Award, which includes $25,000, is sponsored by Novartis Pharmaceuticals Corp. and honors those whose advances in research, education and clinical practice have had a major impact on the diabetes field.
Bennett was recognized for his career-spanning study of the epidemiology of type 2 diabetes in the Pimas of the Gila River Indian Community. In 1964-1965, he worked on the study that first showed that the Pimas of this community have the highest rate of type 2 diabetes in the world. His ongoing studies have since provided a longitudinal look at the natural history of diabetes, highlighting the role of obesity, raised insulin levels and insulin resistance in the progression of the disease and its complications. From February 1985 to July 2000, Bennett was chief of the Phoenix Epidemiology and Clinical Research Branch. He is now chief of the biometry and data management section of the branch. He also directs the World Health Organization collaborating center for design, methodology and analysis of epidemiological and clinical research in non-insulin dependent diabetes. Novartis gave its Young Investigator Award to NIDDK grantee Dr. Steven Kahn, associate director of the Diabetes Endocrinology Research Center at the University of Washington School of Medicine. Read Wins Young Investigator Award
Up to Top |